Raciwell Pharma Private Limited, a active private limited company, was established on 03 January 2017 in Mumbai, Maharashtra, India. Engaging in market gardening within the agriculture sector, it holds CIN: U01100MH2017PTC289219. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Devendra Nath Mishra (Additional Director), Saroj Lata Dwivedi (Additional Director), Pooja Dwivedi (Additional Director). Past directors included Mohd Shameem Khan, Sumit Sisodia, Maqsood Mohd. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit 2B 10, Phoenix Paragon Plaza Mall, Bs Marg, Kamani Junction, Kurla (West), Mumbai, Maharashtra, 400070.
U01100MH2017PTC289219
289219
03 January 2017
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Raciwell Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devendra Nath Mishra | Additional Director | 19 Aug 2024 | Current |
| Saroj Lata Dwivedi | Additional Director | 17 Dec 2024 | Current |
| Pooja Dwivedi | Additional Director | 19 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 09 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 28 Jan 2018 | Past |
| Pramod Abcsdd | Director | 05 Dec 2021 | Past |
| Pramod Abcsdd | Director | 02 Mar 2018 | Past |
| Pramod Abcsdd | Director | 05 Dec 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Raciwell Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 65.84% increase. The company also saw a substantial improvement in profitability, with a 127.25% increase in profit. The company's net worth Soared by an impressive increase of 18.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Raciwell Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Raciwell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Raciwell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raciwell Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Saroj Lata Dwivedi was appointed as a Additional Director was appointed as a Additional Director on 17 Dec 2024 & has been associated with this company since 1 year . was documented.
Raciwell Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Devendra Nath Mishra was appointed as a Additional Director was appointed as a Additional Director on 19 Aug 2024 & has been associated with this company since 1 year 4 months . was completed.
The activity Pooja Dwivedi was appointed as a Additional Director was appointed as a Additional Director on 19 Aug 2024 & has been associated with this company since 1 year 4 months . was completed.
Raciwell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Raciwell Pharma Private Limited was registered on 03 Jan 2017 with Roc Mumbai & aged 8 years 11 months as per MCA records. was documented.
The CIN of Raciwell Pharma Private Limited is U01100MH2017PTC289219.
Raciwell Pharma Private Limited is headquartered at Unit 2B 10, Phoenix Paragon Plaza Mall, Bs Marg, Kamani Junction, Kurla (West), Mumbai, Maharashtra, 400070.
Raciwell Pharma Private Limited was incorporated on 03 January 2017.
The current directors of Raciwell Pharma Private Limited are
The primary industry of Raciwell Pharma Private Limited is Agriculture.
Raciwell Pharma Private Limited is unlisted.
The authorized capital of Raciwell Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Raciwell Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX